These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 1617947)
1. Tumour-localizing properties of porphyrins. In vivo studies using free and liposome encapsulated aminolevulinic acid. Fukuda H; Paredes S; Batlle AM Comp Biochem Physiol B; 1992 Jun; 102(2):433-6. PubMed ID: 1617947 [TBL] [Abstract][Full Text] [Related]
2. Tumor-localizing properties of porphyrins. In vitro studies using the porphyrin precursor, aminolevulinic acid, in free and liposome encapsulated forms. Fukuda H; Paredes S; Batlle AM Drug Des Deliv; 1989 Dec; 5(2):133-9. PubMed ID: 2577983 [TBL] [Abstract][Full Text] [Related]
3. The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolaevulinic acid. Implications in cutaneous photodynamic sensitization. Casas A; Fukuda H; Di Venosa G; Batlle AM Br J Dermatol; 2000 Sep; 143(3):564-72. PubMed ID: 10971330 [TBL] [Abstract][Full Text] [Related]
4. ALA and ALA hexyl ester induction of porphyrins after their systemic administration to tumour bearing mice. Perotti C; Casas A; Fukuda H; Sacca P; Batlle A Br J Cancer; 2002 Sep; 87(7):790-5. PubMed ID: 12232765 [TBL] [Abstract][Full Text] [Related]
5. Tissue distribution and kinetics of endogenous porphyrins synthesized after topical application of ALA in different vehicles. Casas A; Fukuda H; Batlle AM Br J Cancer; 1999 Sep; 81(1):13-8. PubMed ID: 10487606 [TBL] [Abstract][Full Text] [Related]
6. Distribution of 5-aminolevulinic acid derivatives and induced porphyrin kinetics in mice tissues. Di Venosa G; Batlle A; Fukuda H; Macrobert A; Casas A Cancer Chemother Pharmacol; 2006 Oct; 58(4):478-86. PubMed ID: 16485117 [TBL] [Abstract][Full Text] [Related]
7. ALA and ALA hexyl ester in free and liposomal formulations for the photosensitisation of tumour organ cultures. Casas A; Perotti C; Saccoliti M; Sacca P; Fukuda H; Batlle AM Br J Cancer; 2002 Mar; 86(5):837-42. PubMed ID: 11875750 [TBL] [Abstract][Full Text] [Related]
8. Topical and intratumoral photodynamic therapy with 5-aminolevulinic acid in a subcutaneous murine mammary adenocarcinoma. Casas A; Fukuda H; Meiss R; Batlle AM Cancer Lett; 1999 Jul; 141(1-2):29-38. PubMed ID: 10454240 [TBL] [Abstract][Full Text] [Related]
9. Comparation of liposomal formulations of ALA Undecanoyl ester for its use in photodynamic therapy. Di Venosa G; Hermida L; Fukuda H; Defain MV; Rodriguez L; Mamone L; MacRobert A; Casas A; Batlle A J Photochem Photobiol B; 2009 Aug; 96(2):152-8. PubMed ID: 19560367 [TBL] [Abstract][Full Text] [Related]
10. The effect of folic acid on porphyrin synthesis in tumors and normal skin of mice treated with 5-aminolevulinic acid or methyl 5-aminolevulinate. Ma L; Steindal AE; Juzeniene A; Iani V; Moan J Photochem Photobiol Sci; 2006 Aug; 5(8):755-9. PubMed ID: 16886091 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of aminolevulinic acid based photodynamic therapy by adriamycin. Casas A; Fukuda H; Riley P; del C Batlle AM Cancer Lett; 1997 Dec; 121(1):105-13. PubMed ID: 9459181 [TBL] [Abstract][Full Text] [Related]
12. ALA and ALA hexyl ester-induced porphyrin synthesis in chemically induced skin tumours: the role of different vehicles on improving photosensitization. Casas A; Perotti C; Fukuda H; Rogers L; Butler AR; Batlle A Br J Cancer; 2001 Nov; 85(11):1794-800. PubMed ID: 11742504 [TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts. Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. Hua Z; Gibson SL; Foster TH; Hilf R Cancer Res; 1995 Apr; 55(8):1723-31. PubMed ID: 7712481 [TBL] [Abstract][Full Text] [Related]
15. Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies. Perotti C; Fukuda H; DiVenosa G; MacRobert AJ; Batlle A; Casas A Br J Cancer; 2004 Apr; 90(8):1660-5. PubMed ID: 15083200 [TBL] [Abstract][Full Text] [Related]
16. Photodynamic action of endogenously synthesized porphyrins from aminolevulinic acid, using a new model for assaying the effectiveness of tumoral cell killing. Fukuda H; Casas A; Chueke F; Paredes S; Batlle AM Int J Biochem; 1993 Oct; 25(10):1395-8. PubMed ID: 8224354 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model. Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429 [TBL] [Abstract][Full Text] [Related]
18. Accumulation of porphyrins in plasma and tissues of dogs after delta-aminolevulinic acid administration: implications for photodynamic therapy. Egger NG; Motamedi M; Pow-Sang M; Orihuela E; Anderson KE Pharmacology; 1996 Jun; 52(6):362-70. PubMed ID: 8844786 [TBL] [Abstract][Full Text] [Related]